Nkarta (NKTX) Other Non Operating Income (2019 - 2026)
Nkarta's (NKTX) quarterly Other Non Operating Income came in at $206000.0 in Q1 2026, little changed year-on-year from $205000.0 in Q1 2025, and down 19.53% quarter-over-quarter from $256000.0 in Q4 2025.
Nkarta (NKTX) Other Non Operating Income (2019 - 2026) Analysis & Trends
Nkarta's Other Non Operating Income history runs 8 years deep, the most recent figure standing at $206000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income changed 0.49% year-over-year to $206000.0 in Q1 2026; TTM through Mar 2026 was $2.4 million, a 723.13% increase from a year earlier, with the FY2025 full-year figure at $2.4 million, up 2680.46% from the prior year.
- Other Non Operating Income eased to $206000.0 in Q1 2026 per NKTX's latest filing, from $256000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.7 million in Q3 2025 and bottomed at -$489000.0 in Q4 2022.
- The 5-year median for Other Non Operating Income is $17000.0 (2022), against an average of $134352.9.
- Across the five-year window, Other Non Operating Income slumped 24350.0% in 2022 and jumped 57400.0% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at -$489000.0 in 2022, then surged by 94.89% to -$25000.0 in 2023, then surged by 476.0% to $94000.0 in 2024, then surged by 172.34% to $256000.0 in 2025, then fell by 19.53% to $206000.0 in 2026.
- Per Business Quant, the three latest NKTX Other Non Operating Income figures stand at $206000.0 (Q1 2026), $256000.0 (Q4 2025), and $1.7 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 206,000.00 |
| Dec 31, 2025 | 256,000.00 |
| Sep 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 239,000.00 |
| Mar 31, 2025 | 205,000.00 |
| Dec 31, 2024 | 94,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | -25,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 33,000.00 |
| Dec 31, 2022 | -489,000.00 |
| Sep 30, 2022 | 17,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -6,000.00 |
| Jun 30, 2021 | -5,000.00 |